Application 018902
- Type
- NDA
- Sponsor
- FRESENIUS KABI USA
Application Products
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | FUROSEMIDE | FUROSEMIDE | INJECTABLE;INJECTION | 10MG/ML | No | No |
NDC Listings For This Application
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 51662-1572 | FUROSEMIDE | FUROSEMIDE | HF Acquisition Co LLC, DBA HealthFirst | NDA | Current |
| 51662-1572 | FUROSEMIDE | FUROSEMIDE | HF Acquisition Co LLC, DBA HealthFirst | NDA | Current |
| 51662-1574 | FUROSEMIDE | FUROSEMIDE | HF Acquisition Co LLC, DBA HealthFirst | NDA | Current |
| 51662-1574 | FUROSEMIDE | FUROSEMIDE | HF Acquisition Co LLC, DBA HealthFirst | NDA | Current |
| 51662-1574 | FUROSEMIDE | FUROSEMIDE | HF Acquisition Co LLC, DBA HealthFirst | NDA | Current |
| 51662-1574 | FUROSEMIDE | FUROSEMIDE | HF Acquisition Co LLC, DBA HealthFirst | NDA | Current |
| 51662-1575 | FUROSEMIDE | FUROSEMIDE | HF Acquisition Co LLC, DBA HealthFirst | NDA | Current |
| 55154-9581 | Furosemide | FUROSEMIDE | Cardinal Health 107, LLC | NDA | Current |
| 55154-9581 | Furosemide | FUROSEMIDE | Cardinal Health | NDA | Current |
| 55154-9582 | Furosemide | FUROSEMIDE | Cardinal Health | NDA | Current |
| 55154-9582 | Furosemide | FUROSEMIDE | Cardinal Health 107, LLC | NDA | Current |
| 63323-280 | Furosemide | FUROSEMIDE | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-280 | Furosemide | FUROSEMIDE | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-280 | Furosemide | FUROSEMIDE | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-280 | Furosemide | FUROSEMIDE | Fresenius Kabi USA, LLC | NDA | Current |
| 63323-280 | Furosemide | FUROSEMIDE | Fresenius Kabi USA, LLC | NDA | Current |
| 81565-201 | Furosemide | FUROSEMIDE | Phlow Corporation | NDA | Current |